Trial Profile
Clinical Trials Insight: 700034423
Status:
Planning
Phase of Trial:
Phase II
Latest Information Update: 11 Jun 2008
Price :
$35
*
At a glance
- Drugs Pegloticase (Primary)
- Indications Gout
- Focus Therapeutic Use
- Sponsors EnzymeRx
- 11 Jun 2008 New trial record.